Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific - Summary - MDSpire

Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific

  • By

  • Charles Hua Chiang Siow

  • Shengyuan Yu

  • Surat Tanprawate

  • Shuu-Jiun Wang

  • Elspeth J. Hutton

  • Byung-Kun Kim

  • Min Kyung Chu

  • Norihiro Suzuki

  • Wanakorn Rattanawong

  • Ka Sing Wong

  • Mi Ji Lee

  • Zhao Dong

  • Hebo Wang

  • Xianliang Li

  • Koichi Hirata

  • Takao Takeshima

  • May 28, 2026

  • 0 min

Share

Objective:

To explore how clinicians in the Asia-Pacific region approach migraine diagnosis and management in light of revised guidelines.

Key Findings:
  • 100% participation in both surveys; 64.3% attended the scientific meeting.
  • 12 out of 21 closed-ended statements reached consensus.
  • 93% of participants used ICHD-3 for migraine diagnosis; 79% found it easy to apply.
  • 86% considered anti-CGRP mAbs effective for chronic or episodic migraine.
  • Efficacy, safety, and tolerability were the top selection criteria for anti-CGRP mAbs.
  • Participants evaluated migraine-related disability, depression (100%), anxiety (93%), and sleep disturbances (86%).
Interpretation:

Participants unanimously supported the use of ICHD-3 criteria for diagnosis and endorsed anti-CGRP mAbs for migraine prevention, while advising against their use in children under 12 due to insufficient evidence. They also highlighted the importance of headache diaries and other assessment tools.

Limitations:
  • Consensus may not represent all clinicians in the Asia-Pacific region.
  • Limited data on the use of anti-CGRP mAbs in pediatric populations.
  • Potential bias due to the limited number of specialists involved.
Conclusion:

Consensus was reached on key aspects of migraine diagnosis and management, highlighting the need for more pediatric data.

Original Source(s)

Delphi consensus on the real-world application of the updated diagnostic and treatment guidelines for migraine in Asia Pacific

  • by Charles Hua Chiang Siow, Shengyuan Yu, Surat Tanprawate, Shuu-Jiun Wang, Elspeth J. Hutton, Byung-Kun Kim, Min Kyung Chu, Norihiro Suzuki, Wanakorn Rattanawong, Ka Sing Wong, Mi Ji Lee, Zhao Dong, Hebo Wang, Xianliang Li, Koichi Hirata, Takao Takeshima

  • May 28, 2026

Related Content

The interictal symptom burden in vestibular migraine—a condition in need of recognition

Development and validation of a digital tool to aid in migraine diagnosis

Premenstrual syndrome, premenstrual dysphoric disorder, and coping strategies in women with menstrual migraine